You are viewing the site in preview mode
Skip to main content
| |
Total n = 96
|
Complying group n = 58
|
Non-complying group n = 38
|
P
value
|
|---|
|
Number using G-CSF
|
56 (58.3%)
|
33 (56.9%)
|
23 (60.5%)
|
0.8572)
|
|
Duration of G-CSF (days)
|
14.8 ± 10.8
|
10.7 ± 14.8
|
20.7 ± 22.3
|
0.0491)
|
|
Total cost G-CSF (days)
|
279,731
|
112,763
|
166,968
| |
|
Cost of outpatient visit (dollar)
|
26,131
|
9,306
|
16,825
| |
|
Cost of hospitalization (dollar)
|
253,600
|
103,457
|
150,143
| |
|
NRC (dollar/patient)
|
2,914 ± 594
|
1,944 ± 412
|
4,394 ± 837
|
0.0441)
|
|
RDI (%)
|
82.9 ± 13.5
|
85.2 ± 10
|
79.3 ± 15
|
0.0211)
|
- Data are expressed as the mean (SD) or number (%).1)unpaired t-test, 2)Fisher’s exact test. ECOG PS, Eastern Cooperative Oncology Group performance status. NRC, neutropenia-related costs. RDI, relative dose intensity.
